The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy |
|
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome |
|
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. |
|
Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas |
|
Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome |
|
EWALT: East Meets West in a Multidisciplinary Setting to Improve the Management of Liver Tumors |
|
Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. |
|
Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. |
|
Harvesting the middle hepatic vein with a right hepatectomy does not increase the risk for the donor. |
|
Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification |
|
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. |
|
Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors |
|
High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver |
|
Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases |
|
Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis |
|
Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas |
|
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion |
|
Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study |
|
Preservation of the arterial vascularisation after hepatic artery pseudoaneurysm following orthotopic liver transplantation: long-term results |
|
A prospective analysis of living-liver donation shows a high rate of adverse events |
|
A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia |
|
Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis. |
|
Reply to Letter: "A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group": W |
|
Reply to Letter: "Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on 'Surgical Misinterpretation' of the BCLC Staging System": Real Misinterpretation or Lack of Clarity Within the BCLC? |
|
Respiratory complications: a major concern after right hepatectomy in living liver donors. |
|
Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation. |
|
A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas |
|
Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping |
|
Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. |
|
Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. |
|
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets |
|
TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma. |
|